
Detects infection with a bacterium that causes pneumonia and respiratory tract infections.
Description of the blood test:
The Mycoplasma panel is a dual-antibody laboratory study used to detect an infection caused by Mycoplasma pneumoniae. This unique bacterium lacks a cell wall and is a common cause of “atypical pneumonia” and upper respiratory infections. By testing for both IgM (early response) and IgG (long-term response) simultaneously, the physician can determine the exact stage of the infection—whether it is a new acute illness, a reactivation, or a sign of past exposure. This comprehensive approach is essential for choosing the correct antibiotic therapy, as Mycoplasma is resistant to many standard treatments.
What does the analysis represent?
Recommendations for the test (General)
What can affect the results?
When to take the test?
How to interpret the results?
The interpretation of data is the exclusive responsibility of a pulmonologist or an infectious disease specialist. The values of IgM and IgG for Mycoplasma are clinical markers of the body’s immune status and not a final diagnosis. The physician analyzes the ratio of these antibodies alongside lung auscultation and imaging results (like X-rays). Only an expert can distinguish an active infection from a past one and prescribe the specific class of antibiotics required to eliminate this wall-less bacterium.
Possible further investigations
When does the next step make sense?
A positive result, especially for IgM, indicates that the body is currently fighting the bacteria. Because Mycoplasma can cause prolonged fatigue and lung irritation, the next step is a specialist consultation to ensure you receive the specific treatment needed to prevent the infection from becoming chronic.
👉 If necessary, you can discuss the test results with our specialized — pulmonologist (Doctors – TAMC).